Pharma-Bio Serv (PBSV) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | -19.36% |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 4,325.00% |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | -308.05% |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | -86.30% |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | -8.05% |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | -140.96% |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | -17.38% |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -157.32% |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 56.83% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 24.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 24.59% |
| Jan 31, 2026 | 324.96% |
| Oct 31, 2025 | -334.52% |
| Jul 31, 2025 | -38.36% |
| Apr 30, 2025 | -82.56% |
| Jan 31, 2025 | 113.82% |
| Oct 31, 2024 | -96.73% |
| Jul 31, 2024 | 157.77% |
| Apr 30, 2024 | -446.57% |
| Jan 31, 2024 | 44.81% |
| Oct 31, 2023 | 3,008.91% |
| Jul 31, 2023 | -577.36% |
| Apr 30, 2023 | 138.00% |
| Jan 31, 2023 | -248.06% |
| Oct 31, 2022 | -75.50% |
| Jul 31, 2022 | 151.82% |
| Apr 30, 2022 | 25.04% |
| Jan 31, 2022 | -214.88% |
| Oct 31, 2021 | 196.32% |
| Jul 31, 2021 | -64.41% |